JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
City of Hope Medical Center
University of Nebraska
Eastern Cooperative Oncology Group
Thomas Jefferson University
Mayo Clinic
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Roswell Park Cancer Institute
University of Chicago
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
Case Comprehensive Cancer Center
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
The Methodist Hospital Research Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Washington
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
Mayo Clinic
Angimmune LLC
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Roswell Park Cancer Institute
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
Northwestern University
Northside Hospital, Inc.
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center